All In Biotech

Drug Trial Radar · NCT07695701

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Jul 28, 2026

Primary completion

Aug 2030

Study completion Nov 2030

Sponsor

Sponsor type
Industry
First posted
Jul 10, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aims to evaluate the effect of acoramidis on cardiac functional and structural improvement in participants with ATTR-CM.

Conditions

  • Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
  • Amyloidosis
  • Amyloid Cardiomyopathy
  • Transthyretin Amyloidosis

Interventions

  • Acoramidis (AG10) oral tabletDrug

    Study drug is defined as acoramidis 712 mg (equivalent to 800 mg acoramidis hydrochloride) taken orally twice daily for 36 months of open label treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the effect of acoramidis on cardiac function improvement by CMR in participants with ATTR-CM.Time frame: Month 36

Locations

9 sites in 3 countries. Site status is shown where the registry gives one.

  • Johns Hopkins University 056

    Baltimore, Maryland · Recruiting

  • Washington University in St. Louis - 065

    St Louis, Missouri · Recruiting

  • Philadelphia Heart Institute - 030

    Philadelphia, Pennsylvania · Recruiting

  • National Heart Centre - Singapore - 418

    Singapore, Singapore · Recruiting

  • Hospital Universitari de Bellvitge 249

    Barcelona, Spain · Recruiting

  • Hospital Universitario Juan Ramon Jimenez - 237

    Huelva, Spain · Recruiting

  • Hospital Clinico Universitario de Salamanca - 236

    Salamanca, Spain · Recruiting

  • Hospital Universitario Son Llatzer - 224

    Son Ferriol, Spain · Recruiting

  • Hospital Universitario Puerta de Hierro - 203

    Majadahonda, Madrid, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.